ICD-10 Code D89.43
Secondary mast cell activation
D89.43 is the specific ICD-10-CM code designated for secondary mast cell activation syndrome, a complex immunological condition characterized by the inappropriate and excessive release of mast cell chemical mediators such as histamine, leukotrienes, and tryptase. Unlike primary mast cell disorders where there is a clonal expansion of abnormal mast cells, secondary mast cell activation occurs as a hyper-reactive response driven by an underlying primary disease or external trigger. Clinical presentation involves episodic, multisystem symptoms that can include cutaneous flushing, urticaria, bronchospasm, gastrointestinal distress, postural hypotension, and severe anaphylaxis. This code directly applies to patients whose mast cell hyper-reactivity is secondary to conditions such as severe IgE-mediated allergic hypersensitivities, systemic autoimmune diseases, chronic inflammatory disorders, or specific physical triggers. Proper identification using this code helps clinicians distinguish secondary activation from primary mast cell disorders like systemic mastocytosis or idiopathic mast cell activation syndrome, ensuring targeted treatment of both the underlying cause and the mediator-induced symptoms.
- Secondary mast cell activation syndrome
D89.43 is a valid billable ICD-10 diagnosis code for Secondary mast cell activation. It is found in the 2027 version of the ICD-10 CM Index and can be used in all HIPAA-covered transactions from Oct 01, 2026 - Sep 30, 2027.
Check for any exclusions, inclusions or special notations associated with D89.43
- underlying etiology, if known
- MDC 16 Diseases & Disorders of Blood, Blood Forming Organs, Immunologic Disorders
Reticuloendothelial and Immunity Disorders
ICD-10 code D89.43 is based on the following Tabular structure:
Chapter 3: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism- Section D80-D89: Certain disorders involving the immune mechanism
- Category D89: Other disorders involving the immune mechanism, not elsewhere classified
↑ Parent code:
D89.4 for Mast cell activation syndrome and related disorders
Should you use D89.43 or D8943 (with or without decimal point) when submitting claims?
DO NOT include the decimal point when electronically filing claims as it may be rejected. Some clearinghouses may remove it for you
but to avoid having a rejected claim due to an invalid ICD-10 code, do not include the decimal point when submitting claims electronically.
This note further define, or give examples of, the content of the code or category.
List of terms is included under some codes. These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of “other specified” codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10 CM has a coding convention that requires the underlying condition be sequenced first, if applicable, followed by the manifestation. Wherever such a combination exists, there is a “use additional code” note at the etiology code, and a “code first” note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.
A type 1 Excludes note is a pure excludes. It means 'NOT CODED HERE!' An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
A type 2 Excludes note represents 'Not included here'. An Excludes2 note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When an Excludes2 note appears under a code it is acceptable to use both the code and the excluded code together.
A “code also” note instructs that two codes may be required to fully describe a condition, but this note does not provide sequencing direction. The sequencing depends on the circumstances of the encounter.
Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10 CM has a coding convention that requires the underlying condition be sequenced first, if applicable, followed by the manifestation. Wherever such a combination exists, there is a “use additional code” note at the etiology code, and a “code first” note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.